0001209191-22-034389.txt : 20220603 0001209191-22-034389.hdr.sgml : 20220603 20220603202032 ACCESSION NUMBER: 0001209191-22-034389 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220602 FILED AS OF DATE: 20220603 DATE AS OF CHANGE: 20220603 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dalton Barbara CENTRAL INDEX KEY: 0001591318 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39247 FILM NUMBER: 22996467 MAIL ADDRESS: STREET 1: C/O PFIZER VENTURE INVESTMENTS STREET 2: 235 E. 42ND STREET CITY: NEW YORK STATE: NY ZIP: 10017 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IMARA Inc. CENTRAL INDEX KEY: 0001672619 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 811523849 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 116 HUNTINGTON AVENUE STREET 2: 6TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 617-206-2020 MAIL ADDRESS: STREET 1: 116 HUNTINGTON AVENUE STREET 2: 6TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-06-02 0 0001672619 IMARA Inc. IMRA 0001591318 Dalton Barbara C/O IMARA INC. 116 HUNTINGTON AVE, SIXTH FLOOR BOSTON MA 02116 1 0 0 0 Common Stock 1557722 I By entities affiliated with Pfizer Inc. Stock Options (Right to Buy) 1.07 2022-06-02 4 A 0 8500 0.00 A 2032-06-01 Common Stock 8500 8500 D The reporting person is Managing General Partner, Pfizer Ventures (US) LLC. The reporting person disclaims beneficial ownership of the shares owned by the entities affiliated with Pfizer Ventures (US) LLC except to the extent of her pecuniary interest therein. The option will vest on the first anniversary of the date of grant or, if earlier, the date of Imara's next annual meeting of stockholders following the date of grant. /s/ Michael P. Gray, Attorney-in-Fact 2022-06-03